when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

PFIZER · news · pharmadog

← back to PFIZER

News mentioning PFIZER

194 stories

Jun 18, 26Pfizer CFO to step down; Denali sells a regulatory fast-passbiopharma dive

Jun 18, 26Pfizer CFO to depart; GSK wins approval for UTI drugendpoints

Jun 18, 26What’s next for GLP-1 weight loss drugs?stat

Jun 17, 26STAT+: Advocacy groups petition FDA to withdraw approval of ‘unsafe’ use of antibiotics given to livestockstat

Jun 17, 26STAT+: Pharmalittle: We’re reading about hackers extorting Novo, an FDA about-face, and morestat

Jun 17, 26STAT+: Is Abridge’s ‘patient centered’ claim a bridge too far?stat

Jun 16, 26STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, Germany’s pricing plans, and morestat

Jun 15, 26STAT+: FDA approves Colorado’s plan to import cheaper drugs from Canadastat

Jun 15, 26STAT+: A key European clinical trial registry lacks complete and timely results, an analysis findsstat

Jun 15, 26STAT+: Lilly’s Ajax acquisition may have been worth itstat

Jun 15, 26STAT+: Pharmalittle: We’re reading about Pfizer’s emergency penicillin program, a Sanofi diabetes drug, and morestat

Jun 15, 26STAT+: One California politician’s unexpected crusade against ultra-processed foodstat

Jun 15, 26STAT+: Amid confusion over Pfizer’s emergency penicillin program, newborn is diagnosed with preventable syphilisstat

Jun 12, 26STAT+: Pharmalittle: We’re reading about a discontinued cancer drug, a Novo security breach, and morestat

Jun 12, 26Sciwind has two Western partners for its obesity drug, but is open to moreendpoints

Jun 11, 26STAT+: Pharmalittle: We’re reading about employer coverage of obesity drugs, another Sanofi setback, and morestat

Jun 11, 26STAT+: Enliven Therapeutics’ leukemia drug shows promise in new studystat

Jun 10, 26OB-GYN association, deviating from CDC guidance, issues its own vaccine recommendationsstat

Jun 10, 26STAT+: Hope for Kendall Square’s lab marketstat

Jun 10, 26STAT+: Pharmalittle: We’re reading about U.S. pressure on European drug prices, longer shortages, and morestat

Jun 9, 26STAT+: The shortage of many medicines in the U.S. remains a ‘systemic’ problem, a new analysis findsstat

Jun 9, 26STAT+: Trump’s health care affordability czar takes aim at hospitalsstat

Jun 9, 26Gilead and Merck’s latest trial success and flopstat

Jun 9, 26STAT+: Pharmalittle: We’re reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and morestat

Jun 9, 26GSK boosts cancer pipeline with $11B Nuvalent buyoutbiopharma dive

Jun 9, 26STAT+: Trump’s health care affordability czar touts Medicaid cuts to hospital leadersstat

Jun 8, 26Health workers at the epicenter of Congo’s Ebola outbreak labor with little pay or reststat

Jun 8, 26#ADA26: AstraZeneca's GLP-1 pill cuts weight by 10.5% after six monthsendpoints

Jun 8, 26STAT+: AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trialsstat

Jun 8, 26ADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ optionbiopharma dive

← prevpage 4 of 7next →